|
1
|
Baker CD and Abman SH: Impaired pulmonary
vascular development in bronchopulmonary dysplasia. Neonatology.
107:344–351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kinsella JP, Greenough A and Abman SH:
Bronchopulmonary dysplasia. Lancet. 367:1421–1431. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baraldi E and Filippone M: Chronic lung
disease after premature birth. N Engl J Med. 357:1946–1955. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhandari V: Hyperoxia-derived lung damage
in preterm infants. Semin Fetal Neonatal Med. 15:223–229. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang H, Fu J, Xue X, Yao L, Qiao L, Hou A,
Jin L and Xing Y: Epithelial-mesenchymal transitions in
bronchopulmonary dysplasia of newborn rats. Pediatr Pulmonol.
49:1112–1123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu Y, Fu J, Yang H, Pan Y, Yao L and Xue
X: Hyperoxia-induced methylation decreases RUNX3 in a newborn rat
model of bronchopulmonary dysplasia. Respir Res. 16:752015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wegner M: From head to toes: The multiple
facets of Sox proteins. Nucleic Acids Res. 27:1409–1420. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vervoort SJ, van Boxtel R and Coffer PJ:
The role of SRY-related HMG box transcription factor 4 (SOX4) in
tumorigenesis and metastasis: Friend or foe? Oncogene.
32:3397–3409. 2013. View Article : Google Scholar
|
|
10
|
Tiwari N, Tiwari VK, Waldmeier L, Balwierz
PJ, Arnold P, Pachkov M, Meyer-Schaller N, Schübeler D, van
Nimwegen E and Christofori G: Sox4 is a master regulator of
epithelial-mesenchymal transition by controlling Ezh2 expression
and epigenetic reprogramming. Cancer Cell. 23:768–783. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hasegawa S, Nagano H, Konno M, Eguchi H,
Tomokuni A, Tomimaru Y, Asaoka T, Wada H, Hama N, Kawamoto K, et
al: A crucial epithelial to mesenchymal transition regulator,
Sox4/Ezh2 axis is closely related to the clinical outcome in
pancreatic cancer patients. Int J Oncol. 48:145–152. 2016.
View Article : Google Scholar
|
|
12
|
Emery JL and Mithal A: The number of
alveoli in the terminal respiratory unit of man during late
intrauterine life and childhood. Arch Dis Child. 35:544–547. 1960.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jobe AH: The new bronchopulmonary
dysplasia. Curr Opin Pediatr. 23:167–172. 2011. View Article : Google Scholar
|
|
14
|
Crapo JD, Barry BE, Gehr P, Bachofen M and
Weibel ER: Cell number and cell characteristics of the normal human
lung. Am Rev Respir Dis. 126:332–337. 1982.PubMed/NCBI
|
|
15
|
Castranova V, Rabovsky J, Tucker JH and
Miles PR: The alveolar type II epithelial cell: A multifunctional
pneumocyte. Toxicol Appl Pharmacol. 93:472–483. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hou A, Fu J, Yang H, Zhu Y, Pan Y, Xu S
and Xue X: Hyperoxia stimulates the transdifferentiation of type II
alveolar epithelial cells in newborn rats. Am J Physiol Lung Cell
Mol Physiol. 308:L861–L872. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu W, Xu B, Zhao Y, Yang N, Liu C, Wen G
and Zhang B: Wnt5a reverses the inhibitory effect of hyperoxia on
transdifferentiation of alveolar epithelial type II cells to type I
cells. J Physiol Biochem. 71:823–838. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pain M, Bermudez O, Lacoste P, Royer PJ,
Botturi K, Tissot A, Brouard S, Eickelberg O and Magnan A: Tissue
remodelling in chronic bronchial diseases: from the epithelial to
mesenchymal phenotype. Eur Respir Rev. 23:118–130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee JM, Shin JO, Cho KW, Hosoya A, Cho SW,
Lee YS, Ryoo HM, Bae SC and Jung HS: Runx3 is a crucial regulator
of alveolar differentiation and lung tumorigenesis in mice.
Differentiation. 81:261–268. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang C, Liu X, Chen Z, Huang H, Jin Y,
Kolokythas A, Wang A, Dai Y, Wong DT and Zhou X: Polycomb group
protein EZH2-mediated E-cadherin repression promotes metastasis of
oral tongue squamous cell carcinoma. Mol Carcinog. 52:229–236.
2013. View
Article : Google Scholar
|
|
21
|
Penzo-Méndez AI: Critical roles for SoxC
transcription factors in development and cancer. Int J Biochem Cell
Biol. 42:425–428. 2010. View Article : Google Scholar :
|
|
22
|
Dy P, Penzo-Méndez A, Wang H, Pedraza CE,
Macklin WB and Lefebvre V: The three SoxC proteins - Sox4, Sox11
and Sox12 - exhibit overlapping expression patterns and molecular
properties. Nucleic Acids Res. 36:3101–3117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hoser M, Potzner MR, Koch JM, Bösl MR,
Wegner M and Sock E: Sox12 deletion in the mouse reveals
nonreciprocal redundancy with the related Sox4 and Sox11
transcription factors. Mol Cell Biol. 28:4675–4687. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maeda Y, Davé V and Whitsett JA:
Transcriptional control of lung morphogenesis. Physiol Rev.
87:219–244. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang D, Hao T, Pan Y, Qian X and Zhou D:
Increased expression of SOX4 is a biomarker for malignant status
and poor prognosis in patients with non-small cell lung cancer. Mol
Cell Biochem. 402:75–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Medina PP, Castillo SD, Blanco S,
Sanz-Garcia M, Largo C, Alvarez S, Yokota J, Gonzalez-Neira A,
Benitez J, Clevers HC, et al: The SRY-HMG box gene, SOX4, is a
target of gene amplification at chromosome 6p in lung cancer. Hum
Mol Genet. 18:1343–1352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vervoort SJ, Lourenço AR, van Boxtel R and
Coffer PJ: SOX4 mediates TGF-β-induced expression of mesenchymal
markers during mammary cell epithelial to mesenchymal transition.
PLoS One. 8:e532382013. View Article : Google Scholar
|
|
28
|
Parvani JG and Schiemann WP: Sox4, EMT
programs, and the metastatic progression of breast cancers:
Mastering the masters of EMT. Breast Cancer Res. 15:R722013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani
RS, Tomlins SA, Mehra R, Laxman B, Cao X, Yu J, et al: Repression
of E-cadherin by the polycomb group protein EZH2 in cancer.
Oncogene. 27:7274–7284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu Y, Liu X, Zhang H, Fu J and Xue X:
dynamic changes of Bax/Bcl-2 expression in lung tissue and
fibroblasts of neonatal rats after inhaling high concentration
oxygen. J Appl Clin Pediatr. 26:589–592. 2011.
|
|
31
|
Zhou Y, Wang X, Huang Y, Chen Y, Zhao G,
Yao Q, Jin C, Huang Y, Liu X and Li G: Downregulated SOX4
expression suppresses cell proliferation, metastasis and induces
apoptosis in Xuanwei female lung cancer patients. J Cell Biochem.
116:1007–1018. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hur W, Rhim H, Jung CK, Kim JD, Bae SH,
Jang JW, Yang JM, Oh ST, Kim DG, Wang HJ, et al: SOX4
overexpression regulates the p53-mediated apoptosis in
hepatocellular carcinoma: Clinical implication and functional
analysis in vitro. Carcinogenesis. 31:1298–1307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie
Y, Li S, Tang G, Tang H and He X: MicroRNA-124 inhibits
proliferation and induces apoptosis by directly repressing EZH2 in
gastric cancer. Mol Cell Biochem. 392:153–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kage H and Borok Z: EMT and interstitial
lung disease: A mysterious relationship. Curr Opin Pulm Med.
18:517–523. 2012.PubMed/NCBI
|
|
35
|
Pan X, Zhao J, Zhang WN, Li HY, Mu R, Zhou
T, Zhang HY, Gong WL, Yu M, Man JH, et al: Induction of SOX4 by DNA
damage is critical for p53 stabilization and function. Proc Natl
Acad Sci USA. 106:3788–3793. 2009. View Article : Google Scholar : PubMed/NCBI
|
